INSM Stock Summary and Trading Ideas (Insmed | NASDAQ:INSM)

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

What symbol and exchange does Insmed shares trade?

Insmed trades on the NASDAQ stock market under the symbol INSM.

What is Insmed stock price doing today?

As of December 22, 2025, INSM stock price climbed to $175.76 with 2,520,560 million shares trading.

What is Insmed's Beta?

INSM has a beta of 0.75, meaning it tends to be less sensitive to market movements. INSM has a correlation of 0.07 to the broad based SPY ETF.

How much is Insmed worth?

INSM has a market cap of $37.48 billion. This is considered a Large Cap stock.

How much money does Insmed make?

Last quarter Insmed reported $142 million in Revenue and -$1.75 earnings per share. This beat revenue expectation by $27 million and missed earnings estimates by -$.40.

What is the highest and lowest price Insmed traded in the last 3 year period?

In the last 3 years, INSM traded as high as $212.75 and as low as $16.04.

What are the top ETFs holding Insmed?

The top ETF exchange traded funds that INSM belongs to (by Net Assets): VTI, VB, QQQ, VBK, VXF.

Is Insmed (INSM) a good investment?

INSM has outperformed the market in the last year with a return of +153.2%, while the SPY ETF gained +18.8%. In the last 3 month period, INSM beat the market returning +21.4%, while SPY returned +3.5%. However, in the most recent 2 weeks INSM has underperformed the stock market by returning -13.8%, while SPY returned +0.2%.

What are the support and resistance levels for Insmed (INSM)?

INSM support price is $170.13 and resistance is $179.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INSM shares will trade within this expected range on the day.